Progyny, Inc. (PGNY)
PGNY Stock Price Chart
Explore Progyny, Inc. interactive price chart. Choose custom timeframes to analyze PGNY price movements and trends.
PGNY Company Profile
Discover essential business fundamentals and corporate details for Progyny, Inc. (PGNY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
25 Oct 2019
Employees
675.00
Website
https://www.progyny.comCEO
Peter Anevski CPA
Description
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
PGNY Financial Timeline
Browse a chronological timeline of Progyny, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is $0.37.
Earnings released on 7 Aug 2025
EPS came in at $0.48 surpassing the estimated $0.44 by +9.09%, while revenue for the quarter reached $332.87M , beating expectations by +11.58%.
Earnings released on 8 May 2025
EPS came in at $0.48 surpassing the estimated $0.45 by +6.67%, while revenue for the quarter reached $324.04M , beating expectations by +5.27%.
Earnings released on 27 Feb 2025
EPS came in at $0.42 surpassing the estimated $0.37 by +13.51%, while revenue for the quarter reached $298.43M , beating expectations by +7.62%.
Earnings released on 12 Nov 2024
EPS came in at $0.40 surpassing the estimated $0.37 by +8.11%, while revenue for the quarter reached $286.63M , beating expectations by +3.43%.
Earnings released on 6 Aug 2024
EPS came in at $0.43 surpassing the estimated $0.36 by +19.44%, while revenue for the quarter reached $304.09M , missing expectations by -0.44%.
Earnings released on 9 May 2024
EPS came in at $0.39 surpassing the estimated $0.14 by +178.57%, while revenue for the quarter reached $278.08M , missing expectations by -3.93%.
Earnings released on 27 Feb 2024
EPS came in at $0.32 surpassing the estimated $0.11 by +190.91%, while revenue for the quarter reached $269.94M , missing expectations by -1.52%.
Earnings released on 7 Nov 2023
EPS came in at $0.16 surpassing the estimated $0.12 by +33.33%, while revenue for the quarter reached $280.89M , beating expectations by +2.64%.
Earnings released on 3 Aug 2023
EPS came in at $0.15 surpassing the estimated $0.10 by +50.00%, while revenue for the quarter reached $279.37M , beating expectations by +6.67%.
Earnings released on 8 May 2023
EPS came in at $0.18 surpassing the estimated $0.07 by +157.14%, while revenue for the quarter reached $258.39M , beating expectations by +5.17%.
Earnings released on 27 Feb 2023
EPS came in at $0.03 surpassing the estimated $0.01 by +157.07%, while revenue for the quarter reached $214.32M , beating expectations by +1.20%.
Earnings released on 3 Nov 2022
EPS came in at $0.13 surpassing the estimated $0.05 by +160.00%, while revenue for the quarter reached $205.37M , beating expectations by +5.57%.
Earnings released on 4 Aug 2022
EPS came in at $0.09 surpassing the estimated $0.05 by +80.00%, while revenue for the quarter reached $195.00M , beating expectations by +2.36%.
Earnings released on 5 May 2022
EPS came in at $0.05 surpassing the estimated $0.01 by +525.00%, while revenue for the quarter reached $172.22M , beating expectations by +3.02%.
Earnings released on 28 Feb 2022
EPS came in at $0.15 surpassing the estimated $0.04 by +316.67%, while revenue for the quarter reached $127.55M , missing expectations by -5.26%.
Earnings released on 4 Nov 2021
EPS came in at $0.17 surpassing the estimated $0.06 by +183.33%, while revenue for the quarter reached $122.28M , missing expectations by -5.18%.
Earnings released on 5 Aug 2021
EPS came in at $0.19 surpassing the estimated $0.08 by +137.50%, while revenue for the quarter reached $128.65M , beating expectations by +7.74%.
Earnings released on 6 May 2021
EPS came in at $0.15 surpassing the estimated $0.08 by +87.50%, while revenue for the quarter reached $122.13M , beating expectations by +0.71%.
Earnings released on 24 Feb 2021
EPS came in at $0.07 surpassing the estimated $0.06 by +16.67%, while revenue for the quarter reached $100.30M , beating expectations by +2.63%.
Earnings released on 5 Nov 2020
EPS came in at $0.05 matching the estimated $0.05, while revenue for the quarter reached $98.93M , meeting expectations.
PGNY Stock Performance
Access detailed PGNY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.